To determine the effects of prophylactic urethrectomy (PU) on oncological and perioperative outcomes in patients with bladder cancer (BC) undergoing radical cystectomy (RC).

Methods

This retrospective study analyzed data on 1976 evaluable patients with BC who underwent RC. Patients were drawn from 36 institutions within the Japanese Urological Oncology Group. Oncological outcomes were compared using restricted mean survival times (RMSTs) based on inverse probability of treatment weighting (IPTW)-adjusted Kaplan–Meier curves for non-urinary tract recurrence-free survival (NUTRFS), cancer-specific survival (CSS), and overall survival (OS). Interaction terms within IPTW-adjusted Cox regression models were examined to assess the heterogeneity of treatment effect based on the risk of urethral recurrence (UR). The association between PU, estimated blood loss (EBL), and the incidence of severe postoperative surgical complications (SPSCs) (Clavien-Dindo grade 3 or higher) was analyzed.

Results

Of 1976 patients, 1448 (73.3%) received PU. IPTW adjustment was used to balance baseline characteristics between the treatment groups. Within the 107-month window of patient monitoring, PU showed no survival benefits (NUTRFS difference: 0.2 months [95% confidence interval: −6.8 to 7.3]; CSS, 1.2 [−4.9 to 7.3]; OS, 0 [−6.5 to 6.5]). No significant interactions were observed with factors associated with UR, and PU was associated with unfavorable perioperative outcomes (EBL, 1179 mL vs. 983 mL; SPSC, 14.6% vs. 7.0%).

Conclusions

This study showed that (1) PU was not associated with survival in patients with BC undergoing RC, regardless of UR-associated factors, and (2) PU was associated with unfavorable perioperative outcomes.

CONFLICT OF INTEREST STATEMENT

The authors declare no conflict of interest.

Supporting Information

REFERENCES

1Boorjian SA, Kim SP, Weight CJ, Cheville JC, Thapa P, Frank I. Risk factors and outcomes of urethral recurrence following radical cystectomy. Eur Urol. 2011; 60: 1266–1272.
10.1016/j.eururo.2011.08.030
PubMed Web of Science® Google Scholar
2Gakis G, Black PC, Bochner BH, Boorjian SA, Stenzl A, Thalmann GN, et al. Systematic review on the fate of the remnant urothelium after radical cystectomy. Eur Urol. 2017; 71: 545–557.
10.1016/j.eururo.2016.09.035
PubMed Web of Science® Google Scholar
3Hassan JM, Cookson MS, Smith JA Jr, Chang SS. Urethral recurrence in patients following orthotopic urinary diversion. J Urol. 2004; 172: 1338–1341.
10.1097/01.ju.0000138616.05218.21
PubMed Web of Science® Google Scholar
4Hakozaki K, Kikuchi E, Ogihara K, Shigeta K, Abe T, Miyazaki Y, et al. Significance of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer. Jpn J Clin Oncol. 2021; 51: 287–295.
10.1093/jjco/hyaa168
PubMed Web of Science® Google Scholar
5Laukhtina E, Boehm A, Peyronnet B, Bravi CA, Batista da Costa J, Soria F, et al. Urethrectomy at the time of radical cystectomy for non-metastatic urothelial carcinoma of the bladder: a collaborative multicenter study. World J Urol. 2022; 40: 1689–1696.
10.1007/s00345-022-04025-z
PubMed Web of Science® Google Scholar
6von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008; 61: 344–349.
10.1016/j.jclinepi.2007.11.008
PubMed Web of Science® Google Scholar
7Matsumoto H, Shiraishi K, Azuma H, Inoue K, Uemura H, Eto M, et al. Clinical practice guidelines for bladder cancer 2019 update by the Japanese Urological Association: summary of the revision. Int J Urol. 2020; 27: 702–709.
10.1111/iju.14281
PubMed Web of Science® Google Scholar
8Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004; 240: 205–213.
10.1097/01.sla.0000133083.54934.ae
PubMed Web of Science® Google Scholar
9Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009; 28: 3083–3107.
10.1002/sim.3697
PubMed Web of Science® Google Scholar
10Stekhoven DJ, Bühlmann P. MissForest—non-parametric missing value imputation for mixed-type data. Bioinformatics. 2012; 28: 112–118.
10.1093/bioinformatics/btr597
CAS PubMed Web of Science® Google Scholar
11Austin PC. Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis. Stat Med. 2016; 35: 5642–5655.
10.1002/sim.7084
PubMed Web of Science® Google Scholar
12Xie J, Liu C. Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data. Stat Med. 2005; 24: 3089–3110.
10.1002/sim.2174
CAS PubMed Web of Science® Google Scholar
13Laukhtina E, Mori K, D Andrea D, Moschini M, Abufaraj M, Soria F, et al. Incidence, risk factors and outcomes of urethral recurrence after radical cystectomy for bladder cancer: a systematic review and meta-analysis. Urol Oncol. 2021; 39: 806–815.
10.1016/j.urolonc.2021.06.009
PubMed Web of Science® Google Scholar
14McCaw ZR, Yin G, Wei LJ. Using the restricted mean survival time difference as an alternative to the Hazard ratio for analyzing clinical cardiovascular studies. Circulation. 2019; 140: 1366–1368.
10.1161/CIRCULATIONAHA.119.040680
PubMed Web of Science® Google Scholar
15Schellhammer PF, Whitmore WF Jr. Transitional cell carcinoma of the urethra in men having cystectomy for bladder cancer. J Urol. 1976; 115: 56–60.
10.1016/S0022-5347(17)59067-9
CAS PubMed Web of Science® Google Scholar
16Faysal MH. Urethrectomy in men with transitional cell carcinoma of bladder. Urology. 1980; 16: 23–26.
10.1016/0090-4295(80)90325-8
CAS PubMed Web of Science® Google Scholar
17Beahrs JR, Fleming TR, Zincke H. Risk of local urethral recurrence after radical cystectomy for bladder cancer. J Urol. 1984; 131: 264–266.
10.1016/S0022-5347(17)50341-9
CAS PubMed Web of Science® Google Scholar
18Lopez-Almansa M, Molina R, Huben RP. Transitional cell carcinoma of the urethra in men after radical cystectomy for bladder cancer. Is prophylactic urethrectomy indicated? Br J Urol. 1988; 61: 507–509.
10.1111/j.1464-410X.1988.tb05091.x
CAS PubMed Web of Science® Google Scholar
19Chang SS, Bochner BH, Chou R, Dreicer R, Kamat AM, Lerner SP, et al. Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline. J Urol. 2017; 198: 552–559.
10.1016/j.juro.2017.04.086
PubMed Web of Science® Google Scholar
20Witjes JA, Babjuk M, Bellmunt J, Bruins HM, de Reijke TM, de Santis M, et al. EAU-ESMO consensus statements on the Management of Advanced and Variant Bladder Cancer—an International Collaborative Multistakeholder Effort†. Eur Urol. 2020; 77: 223–250.
10.1016/j.eururo.2019.09.035
PubMed Web of Science® Google Scholar
21Huguet J. Management of the male urethra before and after cystectomy: from the prophylactic urethrectomy to the intraoperative frozen section biopsy of the urethral margin. Actas Urol Esp. 2011; 35: 552–558.
10.1016/j.acuro.2011.04.009
CAS PubMed Web of Science® Google Scholar
22Chan Y, Fisher P, Tilki D, Evans CP. Urethral recurrence after cystectomy: current preventative measures, diagnosis and management. BJU Int. 2016; 117: 563–569.
10.1111/bju.13370
PubMed Web of Science® Google Scholar
23Laukhtina E, Rajwa P, Mori K, Moschini M, D'Andrea D, Abufaraj M, et al. Accuracy of frozen section analysis of urethral and ureteral margins during radical cystectomy for bladder cancer: a systematic review and diagnostic meta-analysis. Eur Urol Focus. 2022; 8: 752–760.
10.1016/j.euf.2021.05.010
PubMed Google Scholar
24Coutts AG, Grigor KM, Fowler JW. Urethral dysplasia and bladder cancer in cystectomy specimens. Br J Urol. 1985; 57: 535–541.
10.1111/j.1464-410X.1985.tb05862.x
CAS PubMed Web of Science® Google Scholar
25Joniau S, Shabana W, Verlinde B, Van Poppel H. Prepubic urethrectomy during radical cystoprostatectomy. Eur Urol. 2007; 51: 915–921.
10.1016/j.eururo.2006.09.046
PubMed Web of Science® Google Scholar

Citing Literature

Volume31, Issue9

September 2024

Pages 1009-1016

Filename	Description
iju15505-sup-0001-FigureS1.pdfPDF document, 90.1 KB	Figure S1.
iju15505-sup-0002-TableS1.xlsxExcel 2007 spreadsheet , 11.7 KB	Table S1.
iju15505-sup-0003-TableS2.xlsxExcel 2007 spreadsheet , 13.9 KB	Table S2.
iju15505-sup-0004-TableS3.xlsxExcel 2007 spreadsheet , 14.2 KB	Table S3.
iju15505-sup-0005-TableS4.xlsxExcel 2007 spreadsheet , 9.7 KB	Table S4.
iju15505-sup-0006-TableS5.xlsxExcel 2007 spreadsheet , 10.9 KB	Table S5.

Oncological outcomes of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer: A nationwide multi-institutional study

Abstract

Objectives

Methods

Results

Conclusions

CONFLICT OF INTEREST STATEMENT

Supporting Information

REFERENCES

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Oncological outcomes of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer: A nationwide multi-institutional study

Abstract

Objectives

Methods

Results

Conclusions

CONFLICT OF INTEREST STATEMENT

Supporting Information

REFERENCES

Citing Literature

References

Related

Information